ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Shanghai RAAS Blood Products Co., Ltd. clinical trials

Part of Haier Group, which holds 29.90% of voting rights as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 4 studies whose lead sponsor is Shanghai RAAS Blood Products Co., Ltd. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Shanghai RAAS Blood Products with Sanofi and Hoffmann-La Roche →

Pipeline: 1 program

Each counted once: 1 with a study Shanghai RAAS Blood Products Co., Ltd. leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Shanghai RAAS Blood Products Co., Ltd.’s own registered studies; Shanghai RAAS Blood Products Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Shanghai RAAS Blood Products Co., Ltd.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Shanghai RAAS Blood Products Co., Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 4 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now4100%Recruiting 2 · Not yet recruiting 2

Phase

  • Phase 23
  • Phase 31
  • Phase 11

Where

  • China3

Over the years

  1. 24
  2. 25
  3. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shanghai RAAS Blood Products Co., Ltd.

  • Shanghai RAAS Blood Products Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies

Studies

Recruiting first, then most recently updated. Showing 4 of 4.